A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving Rituximab
Primary biliary cirrhosis (PBC) is a progressive liver disease for which limited therapies are recommended. Rituximab, an anti-CD20 monoclonal antibody, is expected to be a useful therapeutic regimen for PBC. Previous studies indicated biochemical and immunological improvement in PBC after rituximab...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
S. Karger AG
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656669/ |